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Summary
We define the target, mechanism, and structural basis
of inhibition of bacterial RNA polymerase (RNAP) by
the tetramic acid antibiotic streptolydigin (Stl). Stl binds
to a site adjacent to but not overlapping the RNAP
active center and stabilizes an RNAP-active-center
conformational state with a straight-bridge helix. The
results provide direct support for the proposals that
alternative straight-bridge-helix and bent-bridge-helix
RNAP-active-center conformations exist and that cy-
cling between straight-bridge-helix and bent-bridge-
helix RNAP-active-center conformations is required
for RNAP function. The results set bounds on models
for RNAP function and suggest strategies for design
of novel antibacterial agents.
Introduction
RNA polymerase (RNAP) is the enzyme responsible for
transcription and is the target, directly or indirectly, of
most regulation of transcription. High-resolution struc-
tures have been determined for bacterial RNAP core
(subunit composition β#βαIαIIω; Zhang et al., 1999), bac-
terial RNAP holoenzyme (subunit composition β#βαIαIIωσ;
Vassylyev et al., 2002; Murakami et al., 2002a), and
eukaryotic RNAPII (Cramer et al., 2001; Bushnell and
Kornberg, 2003; Armache et al., 2003). The structures
reveal that bacterial RNAP and eukaryotic RNAPII ex-
hibit striking three-dimensional structural similarity
(Ebright, 2000; Darst, 2001; Cramer, 2002). RNAP has
an overall shape reminiscent of a crab claw. The two
“pincers” of the “claw” define the active-center cleft,
which contains determinants for interactions with DNA
and with the RNA-DNA hybrid and which contains the*Correspondence: ebright@mbcl.rutgers.edu (R.H.E.); arnold@cabm.
rutgers.edu (E.A.)
6 These authors contributed equally to this work.active center. In addition to the active-center cleft,
RNAP contains two other distinct channels: the sec-
ondary channel, which mediates entry of NTP sub-
strates to the active-center cleft; and the RNA-exit
channel, which mediates egress of nascent RNA from
the active-center cleft. The largest subunit (β# in bacte-
rial RNAP; RPB1 in eukaryotic RNAPII) makes up one
pincer and part of the floor of the active-center cleft;
the second-largest subunit (β in bacterial RNAP; RPB2
in eukaryotic RNAPII) makes up the other pincer and
the other part of the floor of the active-center cleft. The
active center is located on the floor of the active-center
cleft, immediately adjacent to the junction of the active-
center cleft and the secondary channel. The active cen-
ter contains a tightly bound catalytic Mg2+ ion, coordi-
nated by three Asp residues, and contains binding sites
for NTP substrates. The downstream face of the active
center is formed by the “bridge helix” (also referred to
as “F helix”), which spans the active-center cleft and
divides the active-center cleft from the secondary
channel, and by the “trigger loop” (also referred to as
the “G/G# loop”), which interacts with the bridge helix.
It has been proposed that alternate straight-bridge-
helix and bent-bridge-helix active-center conforma-
tional states exist and that cycling between alternate
straight-bridge-helix and bent-bridge-helix active-cen-
ter conformational states is important for RNAP trans-
location, for RNAP NTP binding, or for both (Cramer et
al., 2001; Gnatt et al., 2001; Epshtein et al., 2002; Bar-
Nahum et al., 2005).
The tetramic-acid antibiotic streptolydigin (Stl) inhib-
its initiation, elongation, and pyrophosphorolysis by
bacterial RNAP (Siddhikol et al., 1969; Cassani et al.,
1971; McClure, 1980). Stl does not inhibit eukaryotic
RNAPI, RNAPII, or RNAPIII, which share high three-
dimensional structural similarity, but low sequence sim-
ilarity, with bacterial RNAP (Ebright, 2000; Darst, 2001;
Cramer, 2002). Stl exhibits only limited crossresistance
with the inhibitor of bacterial RNAP in current clinical
use in antibacterial therapy, rifampicin (Campbell et al.,
2001), and exhibits only limited or no crossresistance
with other characterized inhibitors of bacterial RNAP,
including microcin J25 (MccJ25; Yuzenkova et al., 2002;
Adelman et al., 2004; Mukhopadhyay et al., 2004),
CBR703 (Artsimovitch et al., 2003), and sorangicin
(Campbell et al., 2005). Because emergence of multi-
antibiotic-resistant bacterial strains has limited the effi-
cacy of antibiotics in current clinical use, new antibiot-
ics with different resistance spectra are urgently
needed. Detailed studies of existing inhibitors of essen-
tial bacterial enzymes, such as bacterial RNAP, can
identify targets for systematic drug development efforts
and can define the nature and location of resistance
mutations that emerge under inhibitor selection pres-
sure. Here, using a combination of genetic, biochemi-
cal, and crystallographic approaches, we define the
target, mechanism, and structural basis of inhibition of
bacterial RNAP by Stl.
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Target of Stl
Single-amino-acid substitutions resulting in resistance
to Stl (Stlr) have been reported in residues 543–546 of
the RNAP β subunit (Heisler et al., 1993) and in residues
792–793 of the RNAP β# subunit (Severinov et al., 1995;
Yang and Price, 1995; residues numbered as in Esche-
richia coli RNAP). In the three-dimensional structure of
RNAP (Zhang et al., 1999; Vassylyev et al., 2002), the
implicated residues map to two distinct, nonadjacent
regions, separated by w15 Å. The apparent existence
of two distinct, nonadjacent regions important for func-
tion of Stl raises the issue of whether Stl interacts with
the first region, the second region, or both.
To define systematically the determinants for func-
tion of Stl, we performed saturation mutagenesis of the
genes encoding the RNAP β and β# subunits and iso-
lated and characterized additional Stlr mutants. We
performed saturation mutagenesis using a set of 20
“doped” oligodeoxyribonucleotide primers—designed
to introduce all possible nucleotide substitutions at all
codons for residues that are solvent exposed and lo-
cated within 20 Å of the previously reported Stlr sub-
stitutions (see Table S1 in the Supplemental Data
available with this article online). We isolated 72 inde-
pendent StlR mutants (Table S2). Sequencing indicates
that 70 of the 72 independent Stlr mutants are single-
substitution mutants. The single-substitution mutants
comprise 26 distinct substitutions, involving five sites
within β (543, 544, 545, 570, and 571) and 13 sites within
β# (788, 791, 793, 798, 926, 930, 931, 937, 940, 1136,
1137, 1139, and 1246) (Table 1, Figures 1A and 1B).
Most StlR substitutions affect residues that are con-
served in bacterial RNAP but are not conserved in
eukaryotic RNAPI, RNAPII, and RNAPIII, consistent
with the known specificity of Stl for bacterial RNAP
(Figures 1A and 1B). Each StlR mutant is able to com-
plement a corresponding temperature-sensitive mutant
for growth at the nonpermissive temperature, indicating
that each StlR RNAP derivative is functional in tran-
scription—sufficiently functional to support viability
(Table 1). Four StlR RNAP derivatives were purified and
verified to be functional in transcription and to exhibit
resistance to Stl in vitro (Figure S1).
The StlR substitutions define a determinant with ap-
proximate dimensions of 30 Å × 15 Å × 10 Å (Figure 1C).
The determinant includes both of the regions previously
reported to be important for function of Stl (Heisler et
al., 1993; Severinov et al., 1995; Yang and Price, 1995),
as well as the intervening region. The determinant en-
compasses three structural elements within RNAP: the
“Stl pocket” (residues 543–545 and 570–571 of β), the
bridge helix (also referred to as F helix; residues 788–
798 of β#), and the “trigger loop” (also referred to as
the “G-G# loop”; 930–940, 1136–1139, and 1246 of β#)
(Figure 1C). The determinant is located adjacent to but
does not overlap the RNAP active center (Figure 1C).
The determinant is located adjacent to, and to a
small extent overlaps, the binding site for the inhibitor
MccJ25 (Yuzenkova et al., 2002; Adelman et al., 2004;
Mukhopadhyay et al., 2004). To determine whether Stl
and MccJ25 compete for binding to RNAP, we per-
formed fluorescence-resonance-energy-transfer com-
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petition assays (methods as in Mukhopadhyay et al.
2004]; Figure S2). The results indicate that interaction
f RNAP with Stl and interaction of RNAP with MccJ25
re mutually exclusive. The results further indicate that
d for interaction of RNAP with Stl is 15 ± 2 M, a value
hat equals, within experimental error, Ki for inhibition of
NAP by Stl (18 ± 3 M; Figure S1; see also Siddhikol et
l. [1969]; Cassani et al. [1971]; McClure [1980]). We
nfer that the determinant represents, at least in part,
he binding site for Stl (as opposed to an allosteric de-
erminant required for function but not for binding).
ffects of Stl on RNAP Translocational State
he fact that Stl inhibits initiation, elongation, and pyro-
hosphorolysis (the reverse reaction of nucleotide
ddition) (Siddhikol et al., 1969; Cassani et al., 1971;
cClure, 1980) suggests that Stl inhibits a reaction
ommon to these three processes: i.e., phosphodies-
er-bond formation/breakage or RNAP translocation. To
ssess effects of Stl on RNAP translocational state, we
erformed exonuclease-III DNA-footprinting experi-able 1. StlR Isolates from Saturation Mutagenesis and Selection
Number of Ability to
mino Acid Independent Complement MIC*
ubstitution Isolates rpoBts or rpoCts (g/ml)
poB
ingle-substitution mutants
43Ala/Pro 1 + >20
43Ala/Thr 3 + 10
43Ala/Val 6 + >20
44Gly/Arg 2 + >20
45Phe/Cys 3 + >20
45Phe/Ile 2 + >20
45Phe/Leu 2 + >20
45Phe/Ser 2 + >20
70Gly/Cys 2 + 10
71Leu/Arg 3 + 20
poC
ingle-substitution mutants
88Leu/Met 8 + >20
88Leu/Val 1 + >20
91Ala/Gly 1 + >20
93Ser/Phe 6 + 20
98Arg/Ile 1 + 10
26Pro/Leu 1 + 5
30Leu/Met 3 + 10
31Thr/Ile 4 + 10
37Ile/Asn 3 + 20
40Ala/Val 1 + 5
136Gly/Arg 1 + 10
137Gly/Asp 1 + 10
139Pro/Arg 1 + >20
139Pro/Leu 5 + 20
139Pro/Ser 3 + 10
246Val/Gly 4 + 10
ultiple-substitution mutants
136Gly/Ser; 1 + 20
1139Pro/Ala
138Leu/Val; 1 + 10
1139Pro/Thr
Minimal inhibitory concentration; 2–3 g/ml for wild-type rpoB
nd rpoC.
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543ments (Guajardo et al., 1998; Bar-Nahum et al., 2005),
analyzing a transcription elongation complex con-
taining a 16 nt RNA product with a nonextendable,
3#-deoxy-3#-amino terminus (Figure 2). The results indi-
cate that Stl stabilizes the posttranslocated and pre-
translocated states (state 1 and state 0) relative to the
backtracked state (state −1) by a factor of w10 and
stabilizes the posttranslocated state relative to the pre-Figure 1. Target of Stl
(A and B) Amino-acid sequence alignments for regions of E. coli RNAP β# subunit (A) and E. coli β subunit (B) in which single-residue
substitutions that confer Stl resistance were obtained (Table 1). Sequences for bacterial RNAP are at top; sequences for human RNAPI,
RNAPII, and RNAPIII are at bottom; sites of single-residue substitutions that confer resistance to Stl are boxed (with E. coli and T. thermophilus
residue numbers). Species names and SwissProt locus identifiers for the sequences are, in order, the following: E. coli (RPOB_ECOLI, RPOC_
ECOLI), Haemophilus influenzae (RPOB_HAEIN, RPOC_HAEIN), Vibrio cholerae (RPOB_VIBCH, RPOC_VIBCH), Pseudomonas aeruginosa
(RPOB_PSEAE, RPOC_PSEAE), Treponema pallidum (RPOB_TREPA, RPOC_TREPA), Bordetella pertussis (RPOB_BORPE, RPOC_BORPE),
Xylella fastidiosa (RPOB_XYLFA, RPOC_XYLFA), Campylobacter jejuni (RPOB_CAMJE, RPOC_CAMJE), Neisseria meningitidis (RPOB_NEIME,
RPOC_NEIMA), Rickettsia prowazekii (RPOB_RICPR, RPOC_RICPR), Chlamydia trachomatis (RPOB_CHLTR, RPOC_CHLTR), Mycoplasma
pneumoniae (RPOB_MYCPN, RPOC_MYCPN), Bacillus subtilis (RPOB_BACSU, RPOC_BACSU), Staphylococcus aureus (RPOB_STAAU,
BACSU, RPOC_STAAU), Mycobacterium tuberculosis (RPOB_MYCTU, RPOC_MYCTU), Synechocystis sp. PCC 6803 (RPOB_SYNY3, RPOC2_
SYNY3), Aquifex aeolicus (RPOB_AQUAE, RPOC_AQUAE), Deinococcus radiodurans (RPOB_DEIRA, RPOC_DEIRA), Thermus thermophilus
(RPOB_THETH, RPOC_THETH), Thermus aquaticus (RPOB_THEAQ, RPOC_THEAQ), Homo sapiens RNAPI (RPA2_HUMAN, RPA1_HUMAN),
Homo sapiens RNAPII (RPB2_HUMAN, RPB1_HUMAN), and Homo sapiens RNAPIII (RPC2_HUMAN, RPC1_HUMAN).
(C) Three-dimensional structure of RNAP showing locations of sites of single-residue substitutions that confer resistance to Stl (high-level
resistance in red; moderate-level resistance in pink; Table 1). Two orthogonal views are shown: left, view directly into the NTP-uptake channel,
toward the active-center Mg2+ (white sphere); right, view directly into the RNAP-active-center cleft, toward the active-center Mg2+. Atomic
coordinates are for T. thermophilus RNAP holoenzyme (Vassylyev et al., 2002; σ subunit and β# subunit dispensable region omitted for clarity).translocated state by a factor of w2 (Figures 2C and
2D). Effects of Stl on RNAP translocational state are
qualitatively similar to but quantitatively less than ef-
fects of the incoming NTP on RNAP translocational
state (Figures 2C and 2D; see Bar-Nahum et al. [2005]).
We conclude that Stl affects RNAP translocational state
and suggest that effects on RNAP translocational state
may be associated with the mechanism of inhibition.
Cell
544Figure 2. Effects of Stl on RNAP Translocational State
Data are from exonuclease-III DNA-footprinting experiments (Guajardo et al., 1998; Bar-Nahum et al., 2005), analyzing a transcription elonga-
tion complex containing a 16 nt RNA product with a nonextendable, 3#-deoxy-3#-amino terminus (TEC16).
(A) DNA fragment used in analysis of TEC16. Gray boxes, −35 element, −10 element, and transcription start site (with arrow); red box, halt
site (first G in template strand of transcribed region); *, [32P]-phosphate.
(B) Predicted structural organization of the backtracked state (top; state −1), the pretranslocated state (middle; state 0), and the posttranslo-
cated state (bottom; state +1) of TEC16, and corresponding predicted 32P-labeled products upon exonuclease-III footprinting (architecture of
RNAP [gray], DNA [black], and RNA [red] in transcription elongation complex as in Korzheva et al. [2000]; distance between RNAP active
center [blue circle] and exonuclease-III stop point at RNAP trailing edge [arrow] as in Metzger et al. [1989], Wang et al. [1995]).
(C) Observed 32P-labeled products upon exonuclease-III footprinting of TEC16, TEC16 in the presence of 20 M Stl, and TEC16 in the
presence of 50 M complementary incoming NTP (GTP) (10 min reactions).
(D) Inferred relative abundances of the backtracked state, the pretranslocated state, and the posttranslocated state—shown as scans of
bands in (C) (in panels) and as normalized integrated peak areas (beneath panels).Table 2. Crystallographic Data and Refinement Statistics
Crystallographic Data
RNAP-Stl RNAP
Beamline BNLS X25 BNLS X25
Space group P65 P65
Temperature (°C) −165 −165
Resolution range (Å) 30.0–3.0 30.0–3.3
Cell parameters, a (Å) 237.0 236.2
b (Å) 237.0 236.2
c (Å) 250.0 249.9
Completeness (%) (highest shell) 87.8 (74.1) 98.5 (93.7)
Reflections (total/unique) 795,119/139,391 532,757/115,975
Rmerge (%) 12.4 13.8
Refinement Statistics
RNAP-Stl RNAP
Space group P32 P32
Resolution range (Å) 30.0–3.0 30.0–3.3
Number of reflections 244,746 196,181
Rfactor (%) 26.1 28.2
Free Rfactor (%) 28.1 32.0
Number of refined atoms 54,056 53,964
Luzzati error (Å) 0.60 0.57
Mean Bfactor (Å2) 72 (RNAP), 49 (Stl) 74
Rfree = Σ |Fo − Fc| / |Fo| for 0.8% of the data with |Fo| R 0 sequestered from the calculations. The crystals have the symmetry of space group
P32 with perfect (50%) hemihedral twinning and twinning operator (−h, −k, l), leading to apparent hexagonal (P6/m) intensity symmetry.
Processing and scaling were carried out in P65 followed by expansion to P32 for structure solution and refinement.
Transcription Inhibition by Streptolydigin
545Figure 3. Structural Basis of Inhibition by Stl:
Interactions with RNAP
(A) Structure of Stl.
(B) Structure of RNAP-Stl: electron density
for Stl binding region. Gray, 3Fo − 2Fc
electron density map [contoured at 1.0 σ;
phases from density modification, using
noncrystallographic symmetry (NCS) averag-
ing and solvent flipping, prior to inclusion of
Stl in the model; Fc from NCS averaging and
reconstruction; see Supplemental Data]; cyan,
RNAP; green, Stl.
(C) Structure of RNAP-Stl: structure of Stl
binding region. Cyan, RNAP; cyan dashed
line, disordered or poorly ordered RNAP resi-
dues; green, Stl; red and pink, substitutions
conferring high-level and moderate-level re-
sistance to Stl (Figure 1A; Table 1).Structural Basis of Inhibition by Stl: Interactions
with RNAP and Modeled Interactions with
Transcription Elongation Complex
To define the structural basis of inhibition by Stl, we have
determined the crystal structure of Thermus thermophilus
RNAP holoenzyme in complex with Stl at 3.0 Å resolution
(Table 2, Figures 3B and 3C, Figures S3–S5). (Stl inhibits
T. thermophilus RNAP with Ki = 1.8 ± 0.4 M [Figure
S6].) For direct comparison, we have determined the
crystal structure of T. thermophilus RNAP holoenzyme
alone, in the identical crystal form, at 3.3 Å resolution
(Table 2, Figures S3 and S4). The structures define the
binding site for Stl and define changes in RNAP-active-
center conformation induced by Stl.Stl interacts with three structural elements within
RNAP: the Stl pocket, the bridge helix, and the trigger-
loop region (Figures 3B and 3C). The Stl streptolol moi-
ety interacts with the Stl pocket and bridge helix, and
the Stl tetramic-acid moiety interacts with the trigger-
loop region (Figures 3A–3C).
Stl is located on the floor of the RNAP-active-center
cleft, adjacent to but not overlapping the RNAP active
center. Stl is remote from the NTP-uptake channel
(Zhang et al., 1999; Adelman et al., 2004; Mukhopad-
hyay et al., 2004) and the modeled positions of the NTP
entry site (Sosunov et al., 2003; Westover et al., 2004a;
also referred to as “E site”), the NTP preinsertion site
(Kettenberger et al., 2004), and the NTP insertion site
Cell
546Figure 4. Structural Basis of Inhibition by Stl: Modeled Interactions with Transcription Elongation Complex
Modeled structure of transcription elongation complex containing Stl. To model positions of the DNA template strand, the DNA nontemplate
strand, and the RNA product (blue, cyan, and red nucleic acids), nucleic acids from a structure of the yeast RNAPII transcription elongation
complex (Kettenberger et al., 2004; PDB accession 1Y1W) were built into the structure of RNAP-Stl (superimposition based on Cα atoms of
residues 482, 822, and 829 of yeast RNAPII RPB1 and Cα atoms of residues 740, 1079, and 1086 of T. thermophilus RNAP β#). To model
positions of an NTP at the insertion site (IS), an NTP at the entry site proposed in Westover et al. (2004a) (ES), and an NTP at the preinsertion
site proposed in Kettenberger et al. (2004) (PS) (red, gray, and black NTPs), NTPs from structures of yeast RNAPII transcription elongation
complexes containing bound NTPs (Westover et al., 2004a; Kettenberger et al., 2004; PDB accessions 19RS, 1R9T and 1Y77) were built into
the structure (superimposition as above).(Korzheva et al., 2000; Sosunov et al., 2003; Westover
et al., 2004a; Kettenberger et al., 2004) (Figure 4; >9 Å
from each); thus, Stl is not positioned to interfere di-
rectly with NTP uptake, NTP entry, NTP loading, or NTP
binding. Stl also is remote from the active-center Mg2+
and active-center-Mg2+ coordinating ligands (Zhang et
al., 1999) and from the modeled position of the RNA 3#
end (Korzheva et al., 2000; Sosunov et al., 2003; West-
over et al., 2004a; Kettenberger et al., 2004) (Figure 4;
>15 Å from each); thus, Stl is not positioned to interfere
directly with phosphodiester-bond formation/breakage.
Stl is close to the modeled position of the downstream
fork junction (the downstream separation point of the
DNA template and nontemplate strands; Naryshkin et
al., 2000; Korzheva et al., 2000; Kettenberger et al.,
2004), with the Stl tetramic-acid moiety close to and
possibly in contact with the sugar-phosphate backbone
of the DNA nontemplate strand at the downstream fork
junction (Figure 4); thus, Stl is positioned potentially to
interfere with RNAP function through direct Stl-DNA in-
teractions. Stl also is close to key structural elements
that flank the active center and are proposed to un-
dergo conformational changes in RNAP function and
regulation (Cramer et al., 2001; Gnatt et al., 2001; Vas-
sylyev et al., 2002; Epshtein et al., 2002; Holmes and
Erie, 2003; Bushnell and Kornberg, 2003; Bar-Nahum et
al., 2005) and thus is positioned potentially to interfere
with RNAP function through effects on RNAP-active-
center conformation (see below).
Stl contacts or is close to the majority of residues at
which high-level StlR substitutions are obtained and for
which ordered density is observed in the structure (Fig-
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Rres 3C and 5C). We infer that these residues represent
binding subdeterminant for Stl (Figure 5C). Stl is re-
ote from two residues at which high-level StlR substi-
utions are obtained and for which ordered density is
bserved: β# residues 791 and 793. We infer that these
esidues represent an allosteric functional subdetermi-
ant for Stl (Figure 5C).
Main chain and side chain atoms of β residues 543,
44, and 545 are located directly adjacent to the C4–
7 atoms and the C15 and C16 methyl groups of the
treptolol moiety of Stl (atoms of Stl numbered as in
ee and Rinehart [1980]; Figure 3A). Main chain atoms
f β# residues 784 and 787 and side chain atoms of β#
esidue 788 are located directly adjacent to the C10 and
11 atoms and the C12–C18 epoxide group of the
treptolol moiety of Stl. Side chain atoms of β# residue
139 are located directly adjacent to the C2$ and C3$
toms of the six-membered ring pendant from the
etramic-acid moiety of Stl. StlR substitutions at these
ositions (Table 1, Figures 1A and 1B) are expected
o remove favorable hydrophobic interactions with Stl
nd/or to introduce unfavorable steric interactions
ith Stl. The Leu788/Val StlR substitution introduces
β-branched side chain likely to result in steric hin-
rance with Stl binding (in a manner reminiscent of
et184/Val and Met184/Ile substitutions in HIV-1 re-
erse transcriptase, which result in resistance to the
nti-AIDS drug lamivudine through a steric-hindrance
echanism; see Sarafianos et al. [1999]). Four of these
ositions show sequence differences with eukaryotic
NAPI, RNAPII, and RNAPIII (Figures 1A and 1B), con-
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547sistent with the known lack of sensitivity of eukaryotic
RNAPI, RNAPII, and RNAPIII to Stl.
Structural Basis of Inhibition by Stl: Stabilization
of Straight-Bridge-Helix Active-Center Conformation
Comparison of the structures of RNAP and of the
RNAP-Stl complex reveals that binding of Stl is accom-
panied by striking changes in the conformations of the
bridge helix (Figures 5A–5C) and the trigger loop (Fig-
ures 5B and 5C)—changes that occur in the absence
of other, global changes in conformation (Figure S3). In
the structure of RNAP in the absence of Stl, the bridge
helix is bent and adopts a conformation essentially
identical to that reported by Vassylyev et al. (2002) for
unliganded RNAP (Figure 5A; Figures 5B and 5C, left
panels; Figure S4). In contrast, in the structure of the
RNAP-Stl complex, the bridge helix is straight (Figure
5A; Figures 5B and 5C, right panels; Figure S4). In the
structure of RNAP in the absence of Stl, the trigger loop
interacts with residues of the bridge helix (Figures 5B
and 5C, left panels). In contrast, in the structure of the
RNAP-Stl complex, the trigger loop must move in order
to accommodate Stl, and the base of the trigger loop
adopts a different conformation (Figures 5B and 5C,
right panels).
A bent-bridge-helix conformation has been observed
in all previously reported structures of bacterial RNAP
and complexes thereof (Zhang et al., 1999; Campbell et
al., 2001, 2005; Vassylyev et al., 2002; Murakami et al.,
2002a, 2002b; Artsimovitch et al., 2004; PDB accession
numbers 1HQM, 1I6V, 1IW7, 1L9U, 1L9Z, 1SMY, 1YNJ,
and 1YNN), whereas a straight-bridge-helix conforma-
tion has been observed in all previously reported struc-
tures of eukaryotic RNAPII and complexes thereof
(Cramer et al., 2001; Gnatt et al., 2001; Bushnell et al.,
2002, 2004; Bushnell and Kornberg, 2003; Armache et
al., 2003; Westover et al., 2004a, 2004b; Kettenberger
et al., 2003, 2004; PDB accession numbers 1I3Q, 1I50,
1I6H, 1K83, 1NIK, 1NT9, 1PQV, 1R5U, 1R9S, 1R9T,
1SFO, 1TWA, 1TWC, 1TWF, 1TWG, 1TWH, 1Y1V, 1Y1W,
1Y1Y, 1Y77, and 1WCM). Kornberg and coworkers have
hypothesized that alternative straight and bent-bridge-
helix conformations exist in both bacterial RNAP and
eukaryotic RNAPII, and they have hypothesized that
cycling between alternative straight and bent-bridge-
helix conformations accompanies and possibly drives
RNAP translocation, hypothesizing that the transition
between the pretranslocated state and the posttranslo-
cated state is accompanied by and possibly requires
bending and restraightening of the bridge helix (Cramer
et al., 2001; Gnatt et al., 2001). The “swing-gate” model
and “two-pawl-ratchet” model have elaborated on this
hypothesis (Epshtein et al., 2002; Bar-Nahum et al.,
2005): the swing-gate model proposed a specific mech-
anism by which bridge-helix conformational cycling
could mediate both RNAP translocation and NTP entry
(Epshtein et al., 2002); the two-pawl-ratchet model pro-
posed specific mechanisms by which bridge-helix con-
formational cycling could serve as one of two “pawls”
mediating RNAP translocation and maintaining RNAP
translocational state (Bar-Nahum et al., 2005). Never-
theless, it previously has not been possible to distin-guish between the hypothesis that the different bridge-
helix conformations in structures of bacterial RNAP and
structures of eukaryotic RNAPII solely reflect a species
difference incidental to RNAP function, and the hypoth-
esis that alternative bridge-helix conformational states
exist and may be functionally relevant for both bacterial
RNAP and eukaryotic RNAPII. Crosslinking results con-
sistent with the existence of alternative bridge-helix
conformational states in alternative RNAP transloca-
tional states have been reported, but these results have
permitted no firm conclusions regarding the character
of said states (Epshtein et al., 2002; Bar-Nahum et al.,
2005). The present structures provide direct, unequivo-
cal evidence for the existence of alternative bridge-
helix conformational states in a single RNAP in a single
crystal form.
The structures of RNAP and RNAP-Stl herein were
obtained in identical crystal forms with nearly identical
unit-cell dimensions (Table 2). Therefore, the difference
in bridge-helix conformation in the structure of RNAP-
Stl results can be directly attributed to the presence of
Stl. The difference in bridge-helix conformation in the
structure of RNAP-Stl can be understood in terms of
two specific RNAP-Stl interactions: (1) Stl directly in-
teracts with residues of the bridge helix (Figures 4 and
5); and (2) Stl sterically displaces the trigger loop from
its position in the absence of Stl and, concomitantly,
disrupts potentially stabilizing interactions with the
bent bridge helix that occur in the absence of Stl (Fig-
ures 5B and 5C). We conclude that Stl stabilizes an
RNAP-active-center conformational state having a
straight-bridge helix.
Strikingly, the residues inferred to represent an allo-
steric subdeterminant for Stl, β# residues 791 and 793,
are located at the site at which the bridge helix bends
and make distinct interactions in straight-bridge-helix
and bent-bridge-helix conformational states (“hinge
residues”; Figure 5C). Also, strikingly, both StlR substi-
tutions obtained within this subdeterminant are substi-
tutions expected to disfavor the straight state relative
to the bent state: the β# Ala791/Gly substitution is
predicted to decrease helical propensity (Chou and
Fasman, 1974) and thus is expected to disfavor the
straight state; the β# Ser793/Phe substitution is pre-
dicted to introduce steric clash with trigger-loop resi-
dues in the straight state and thus is expected to disfa-
vor the straight state. We conclude that Stl binding and/
or Stl function requires an RNAP-active-center confor-
mational state having a straight-bridge helix.
Our results are consistent with two alternative
hypotheses. According to the first hypothesis, Stl binds
to an RNAP-active-center conformational state having
a straight-bridge helix and corresponding specific trig-
ger-loop conformation, and Stl inhibits RNAP function
by trapping the RNAP active center in this conforma-
tional state, thereby interfering with conformational cy-
cling important for RNAP function. According to the
second hypothesis, Stl binds to and favors an RNAP-
active-center conformational state having a straight-
bridge helix and corresponding specific trigger-loop
conformation, but Stl inhibits RNAP function by another
mechanism (e.g., direct, steric interference with nucleic
acid preventing translocation, or non-bridge-helix-
Cell
548Figure 5. Structural Basis of Inhibition by Stl: Stabilization of Straight-Bridge-Helix Active-Center Conformation
(A) Bridge-helix conformations in RNAP (red) and RNAP-Stl (blue) and superimposed Fo − Fo difference electron density map (contoured at
3.0 σ; calculated using data sets for RNAP-Stl and RNAP and phases from the refined structure of RNAP-Stl; positive difference density in
blue; negative difference density in red).
(B) Active-center conformations in RNAP (left) and RNAP-Stl (right). Cyan, RNAP; cyan dashed line, disordered or poorly ordered RNAP
residues; white sphere, active-center Mg2+; green, Stl.
(C) Active-center conformations in RNAP (left) and RNAP-Stl (right), showing sites of substitutions conferring high-level Stl resistance (red;
Figure 1A, Table 1), and the inferred binding subdeterminant and allosteric subdeterminant (magenta ovals).related allosteric effects on NTP binding, catalysis, or
translocation). We favor the simpler hypothesis: i.e., Stl
inhibits RNAP function by trapping a straight-bridge-
helix RNAP-active-center conformational state, thereby
interfering with conformational cycling important for
RNAP function. A similar model has been proposed for
α-amanitin, an inhibitor of eukaryotic RNAPII that in-
t
u
b
5
c
f
beracts with the bridge helix from a site within the NTP-
ptake channel (interacting with the “underside” of the
ridge helix in the view orientation in Figures 4, 5B, and
C; Bushnell and Kornberg [2003]). However, in that
ase, no direct evidence has been presented for con-
ormational cycling of the bridge helix, and the possi-
ility that the inhibitor instead functions by at least
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549partly obstructing the NTP-uptake channel and interfer-
ing with NTP uptake (like MccJ25; Adelman et al. [2004];
Mukhopadhyay et al. [2004]) has not been excluded. It
is also possible that a structure of RNAP complexed
with Stl in the presence of bound nucleic acid, which is
not yet available, would yield unexpected insights in
terms of conformation and/or access of substrates that
would modify our current perspective.
Discussion
The results have important implications for understand-
ing the mechanism of RNAP function, specifically the
following:
(1) The structures provide direct support for propos-
als that alternative straight-bridge-helix and bent-
bridge-helix RNAP-active-center conformational states
exist (Cramer et al., 2001; Gnatt et al., 2001; Vassylyev
et al., 2002; Epshtein et al., 2002; Bushnell and Korn-
berg, 2003; Bar-Nahum et al., 2005).
(2) In conjunction with the known inhibition of RNAP
function by Stl (Siddhikol et al., 1969; Cassani et al.,
1971; McClure, 1980) and our results indicating that
bridge-helix hinge residues constitute an allosteric de-
terminant for Stl (Figure 5C), the structures provide
direct support for proposals that cycling between
straight-bridge-helix and bent-bridge-helix RNAP-active-
center conformational states is important for RNAP
function (Cramer et al., 2001; Gnatt et al., 2001; Vassy-
lyev et al., 2002; Epshtein et al., 2002; Bushnell and
Kornberg, 2003; Bar-Nahum et al., 2005).
(3) In conjunction with our results regarding effects of
Stl on RNAP translocational states (Figure 2), the struc-
tures suggest that transition to a straight-bridge-helix
RNAP-active-center conformation disfavors and possi-
bly excludes backtracked states.
(4) In conjunction with our results regarding effects of
Stl on RNAP translocational states (Figure 2), the struc-
tures suggest that transition to a straight-bridge-helix
RNAP-active-center conformation disfavors the pretrans-
located state relative to the posttranslocated state.
Taken together, the results appear to support the ba-
sic proposals of Kornberg and coworkers regarding
bridge-helix conformational cycling in RNAP function
(Cramer et al., 2001; Gnatt et al., 2001), argue against
two more specific models for bridge-helix conforma-
tional cycling in RNAP function (Epshtein et al., 2002;
Bar-Nahum et al., 2005), and set bounds on any future,
more specific model for bridge-helix conformational cy-
cling in RNAP function. The swing-gate model (Ep-
shtein et al., 2002) proposed that transition to a
straight-bridge-helix active-center conformation would
favor backtracked states and pretranslocated states
relative to the posttranslocated state (and expressly
predicted that Stl would stabilize a bent-bridge-helix
active-center conformational state), predictions that
are inconsistent with our results. The version of the
two-pawl-ratchet model (Bar-Nahum et al., 2005) that
was solved analytically and used for quantitative simu-
lations in published work (a version in which parameter
Kb+/Kb− was much less than parameter KFb+/KFb− and
much less than 1 [parameters defined as in Figure S1
of Bar-Nahum et al. (2005)]) proposed that transition toa straight-bridge-helix active-center conformational
state would favor the pretranslocated state relative to
the posttranslocated state—and thus appears to be in-
consistent with our results. However, other versions of
the two-pawl-ratchet model, with different parameters,
are not excluded; such other versions of the two-pawl-
ratchet model are consistent with all results in Bar-
Nahum et al. (2005) and all results herein.
The results also have implications for development
of novel antibiotics. The proximity of the Stl tetramic-
acid moiety to the modeled position of the downstream
fork junction (Figure 4) suggests that attachment of a
DNA binding moiety to the tetramic-acid moiety should
result in increased affinity for transcription complexes
and that attachment of a sequence-specific DNA bind-
ing moiety should result in sequence-specific, poten-
tially gene-specific, increased affinity for transcription
complexes. The recent total synthesis of a tetramic-
acid antibiotic with an aromatic moiety pendant on the
tetramic-acid moiety provides a potential route to such
compounds (Iwata et al., 2005).
Experimental Procedures
Stl
Stl was provided by E. Steinbrecher of Pharmacia & Upjohn, Kala-
mazoo, Michigan.
Plasmids
Plasmid pREII-NHα encodes N-terminally hexahistidine-tagged
E. coli RNAP α subunit under control of tandem lpp and lacUV5
promoters (Niu et al., 1996). Plasmid pRL706 encodes C-terminally
hexahistidine-tagged E. coli RNAP β subunit under control of the
trc promoter (Severinov et al., 1997). Plasmid pRL663 encodes
C-terminally hexahistidine-tagged E. coli RNAP β# subunit under
control of the tac promoter (Wang et al., 1995).
RNAP: E. coli
E. coli RNAP core and holoenzyme were prepared as in Niu et al.
(1996). Derivatives of RNAP core and holoenzyme containing sub-
stitutions in β were prepared from strain XE54 (thi; Tang et al., 1994)
transformed with pRL706 derivatives, using analogous procedures.
Derivatives of RNAP core and holoenzyme containing substitutions
in β# were prepared from strain 397c (rpoCts397 argG thi lac
[λcI857h80St68dlac+]; Christie et al., 1996) transformed with pRL663
derivatives, using analogous procedures. Purities typically were
>95%.
RNAP: T. thermophilus
RNAP holoenzyme was isolated from T. thermophilus strain HB-8
as in Vassylyeva et al. (2002), with an overall yield of w8 mg of
electrophoretically homogeneous protein (>95% purity) per 100 g
of wet cell paste. Quantitative in vitro transcription assays (meth-
ods as in Vassylyeva et al. [2002], Laptenko and Borukhov [2003])
revealed that the preparation contains w80% catalytically active
molecules.
StlR Mutants: Isolation
Saturation mutagenesis and selection of antibiotic-resistant mu-
tants were performed by a variation of the method in Mukhopad-
hyay et al. (2004). A set of doped oligodeoxyribonucleotide primers
corresponding to codons 158–165, 166–173, 443–447, 512–522,
523–532, 535–541, 542–549, and 563–573 of the rpoB gene of plas-
mid pRL706; and codons 325–335, 336–346, 425–429, 726–740,
741–754, 775–790, 791–799, 922–933, 1133–1137, 1138–1146,
1147–1152, and 1239–1248 of the rpoC gene of plasmid pRL663
was synthesized on an AB392 automated synthesizer (Applied Bio-
systems) using solid-phase β-cyanoethylphosphoramidite chemis-
try (sequences in Table S1). The level of “doping” (nucleotide
misincorporation) was selected to yield an average of 0.4–1 substi-
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550tution(s) per molecule of oligodeoxyribonucleotide primer (equa-
tions in Hermes et al. [1989, 1990]). Thus, the nucleotides corre-
sponding to codons 443–447 and 542–649 of rpoB, and 424–429,
1133–1137, and 1147–1152 of rpoC were synthesized using phos-
phoramidite reservoirs containing 92% of the correct phosphor-
amidite and 8% of a 1:1:1:1 mix of dA, dC, dG, and dT phosphor-
amidites (i.e., 94% total correct phosphoramidite and 6% total
incorrect phosphoramidite). The nucleotides corresponding to co-
dons 158–165, 166–173, 512–522, 523–532, 535–541, and 563–573
of rpoB; and codons 325–335, 336–346, 726–740, 741–754, 775–
790, 791–799, 922–933, 1138–1146, and 1239–1248 of the rpoC
were synthesized using phosphoramidite reservoirs containing
98% of the correct phosphoramidite and 2% of a 1:1:1:1 mix of dA,
dC, dG, and dT phosphoramidites, i.e., 98.5% total correct phos-
phoramidite and 1.5% total incorrect phosphoramidite. All other
nucleotides were synthesized using phosphoramidite reservoirs
containing 100% of the correct phosphoramidite. Primer-extension
mutagenesis reactions were performed using the QuikChange Site-
Directed Mutagenesis Kit (Stratagene) with a doped oligodeoxyri-
bonucleotide primer, a complementary wild-type oligodeoxyribo-
nucleotide primer, and pRL706 or pRL663 as template (primers at
75 nM; all other components at concentrations as specified by the
manufacturer). Mutagenized plasmid DNA was introduced by trans-
formation into strain XL1-Blue (hsdR17 recA1 endA1 relA1 gyrA96
lac thi supE44 [F# proAB lacIqZDM15 Tn10], Stratagene). Trans-
formants (w104 cells) were applied to LB-agar plates (Sambrook
and Russell, 2001) containing 200 g/ml ampicillin, plates were in-
cubated 16 hr at 37°C, and plasmid DNA was prepared from the
pooled resulting colonies. The resulting passaged mutagenized
plasmid DNA was introduced by transformation into strain D21f2/
tolC::Tn10 (tolC:Tn10 rfa lac28 proA23 trp30 his51 rpsL173 ampC
tsx81, a strain with cell-envelope defects resulting in increased
susceptibility to hydrophobic agents, including Stl; Fralick and
Burns-Keliher [1994]; E.S., X.W., and R.H.E., unpublished data).
Transformants (w104 cells) were applied to LB-agar plates contain-
ing 2 g/ml Stl, 200 g/ml ampicillin, and 1 mM IPTG, and plates
were incubated 16–24 hr at 37°C. For each StlR clone (identified as
a clone yielding a colony on the original selective plate and also
yielding colonies when restreaked to the same medium and incu-
bated 16 hr at 37°C), plasmid DNA was prepared and was intro-
duced by transformation into strain D21f2/tolC::Tn10. Trans-
formants (w104 cells) were applied to LB-agar plates containing 2
g/ml Stl, 200 g/ml ampicillin, and 1 mM IPTG and, in parallel, to
LB-agar plates containing 200 g/ml ampicillin and 1 mM IPTG.
Plates were incubated 16 hr at 37°C. For each plasmid-linked StlR
clone (identified as a clone yielding comparable numbers of colo-
nies on the plates with and without Stl), the nucleotide sequence
of the mutagenized rpoB or rpoC segment was determined by di-
deoxy nucleotide sequencing.
StlR Mutants: Complementation Assays
For StlR mutants in rpoB, temperature-sensitive strain RL585 (rpo-
BamcI supDts43,74 D[recA-srl]306 lacZam2110 galEKam leuam trpam
sueA rpsL tsx srl301::Tn10-84; Landick et al. [1990]) was trans-
formed with a pRL706 derivative, and transformants (w104 cells)
were applied to LB-agar plates containing 200 g/ml ampicillin and
10 g/ml tetracycline. Plates were incubated 16 hr at 37°C, and
bacterial growth was scored. For StlR mutants in rpoC, temper-
ature-sensitive strain 397c (Christie et al., 1996) was transformed
with a pRL663 derivative. Transformants (w104 cells) were applied
to LB-agar plates containing 200 g/ml ampicillin, plates were in-
cubated 16 hr at 37°C, and bacterial growth was scored.
StlR Mutants: Minimal Inhibitory Concentration Assays
Single colonies of strain D21f2/tolC::Tn10 (Fralick and Burns-Kel-
iher, 1994) transformed with a pRL706 or pRL663 derivative were
inoculated into 3 ml LB containing 200 g/ml ampicillin and incu-
bated 3–4 hr at 37°C with shaking. Diluted aliquots (105 cells in 10
l LB; concentration determined using OD600 = 1 for 109 cells) were
subcultured in 1 ml LB containing 0, 1.25, 2.5, 5, 10, or 20 g/ml
Stl and incubated 16 hr at 37°C with shaking. The minimal inhibitory
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oconcentration (MIC) was defined as the lowest concentration of Stl
that reduced OD600 by R95%.NAP Translocational State: TEC16
eaction mixtures for preparation of transcription elongation com-
lexes containing a 16 nt RNA product with a nonextendable,
#-deoxy-3#-amino terminus (TEC16) contained (200 l) 10 nM
exahistidine-tagged RNAP holoenzyme, 40 nm DNA fragment
acUV5(UHD) 32P-labeled at the 5# end of the DNA template strand
sequence in Figure 2A; prepared by PCR amplification, using du-
lex of annealed 86 nt synthetic oligodeoxyribonucleotides, non-
emplate-strand primer, and 32P-5#-end-labeled template-strand
rimer), 1 mM ApA (Sigma-Aldrich), 50 M 3#-amino-3#-deoxy ATP
IBA), 25 M CTP, 25 M GTP, and 25 M UTP in buffer A (30 mM
EPES [pH 8.0], 100 mM NaCl, 10 mM MgCl2, 1 mM β-mercapto-
thanol, and 0.05% Tween 20). Reactions were initiated by addition
f ApA and NTPs (in 10 l buffer A) to other components (in 190 l
uffer A; preequilibrated 10 min at 37°C) and were allowed to pro-
eed for 10 min at 37°C. TEC16 was adsorbed onto Ni2+-NTA-agar-
se by addition of 200 l Ni2+-NTA-agarose slurry (Qiagen; washed
wice with 2 ml buffer A and resuspended in 200 l buffer A), incu-
ated 10 min at 37°C, and centrifuged at 14,000 × g for 1 min at
°C; was washed three times with 1 ml buffer A containing 1.1 M
Cl (each time with incubation 10 min at 4°C, followed by centrifu-
ation at 14,000 × g for 1 min at 4°C); and was washed four times
ith 1 ml buffer A (each time with incubation 30 s at 4°C, followed
y centrifugation at 14,000 × g for 1 min at 4°C). The resulting Ni2+-
TA-agarose-immobilized, washed NTP-free TEC16 was resus-
ended in 180 l buffer A at 25°C and subdivided into 16 l ali-
uots.
NAP Translocational State: Exonuclease-III DNA Footprinting
o a 16 l aliquot of Ni2+-NTA-agarose-immobilized, washed, NTP-
ree TEC16 (preceding section; used immediately after preparation)
t 25°C was added 2 l buffer A, 2 l 200 M Stl in buffer A, or 2
l 500 M GTP in buffer A and, after 15 s at 25°C, 2 l 5 U/ml
xonuclease III (New England Biolabs). Reactions were allowed to
roceed for 2.5, 5, or 10 min at 37°C and were terminated by addi-
ion of 20 l 80% formamide, 10 mM EDTA, 0.04% bromophenol
lue, and 0.04% xylene cyanol and incubated for 10 min at 65°C.
roducts of the reaction and, in parallel, products of a G+A nucleo-
ide-sequencing reaction (Maxam and Gilbert, 1980) of the same
NA fragment were resolved by urea-PAGE (Sambrook and Rus-
ell, 2001) and quantified using an x/y storage-phosphor scanner
Storm 860, Molecular Dynamics).
tructure Determination: Crystallization and Cryocooling
rystallization and crystal-handling procedures were derived from
rotocols described in Vassylyeva et al. (2002). A stock crystalliza-
ion solution was prepared by adding T. thermophilus RNAP holo-
nzyme (10 mg/ml) in 20 mM Tris-HCl (pH 7.7), 100 mM NaCl, and
% glycerol to an equal volume of 33 mM magnesium formate con-
aining 40 M ZnCl2. A 2 l aliquot of this solution was placed in a
icrobridge sitting-drop or vapor-diffusion hanging-drop crystalli-
ation apparatus. Small (w0.05–0.1 mm) hexagonal crystals formed
ithin 1–2 days and grew to a final size of w0.35 × 0.35 × 0.2
m within 4–5 days. The largest RNAP holoenzyme crystals were
ransferred to a solution of 20 mM MES (pH 5.85), 13 mM magne-
ium formate, 2 mM spermine, 2 mM DTT, 5% PEG 400, and 10%–
5% MPD, with or without 1 mM streptolydigin, for 10–15 min, then
emoved and flash cooled in liquid nitrogen. Only one of every five
o ten crystals diffracted beyond w3.5 Å resolution and a consider-
bly smaller fraction diffracted to 3 Å resolution.
tructure Determination: Data Collection and Reduction
iffraction data for RNAP-Stl and RNAP crystals were collected
t Brookhaven National Laboratory National Synchrotron Light
ource (BNL-NSLS) beamline X-25 and Cornell High Energy Syn-
hrotron Source (CHESS) beamline F1. Data were processed and
caled using HKL 2000 (Otwinowski and Minor [1997]; crystallo-
raphic statistics in Table 2).
tructure Determination: Structure Solution and Refinement
nitial solution of the RNAP-Stl and RNAP structures was carried
ut using molecular-replacement methods in CNS 1.1 (Brünger etal., 1998) using PDB code 1IW7 (Vassylyev et al., 2002) as the
search model. The data were found to have perfect hemihedral
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551twinning (consistent with the prior description of this crystal form
[Vassylyeva et al., 2002; Vassylyev et al., 2002]; twin operator = −h,
−k, l; twin fraction = 0.5) and were detwinned (Yeates, 1997) prior
to structure solution and crystallographic refinement, resulting in a
change of effective space group symmetry from P65 to P32 (with
two RNAP molecules in the asymmetric unit). Early stages of refine-
ment of both the RNAP-Stl and RNAP structures included rigid
body refinement of each RNAP molecule in the asymmetric unit,
followed by rigid body refinement of each subunit of each RNAP
molecule, followed by rigid body refinement of 40 subdivisions
(consisting of w15–200 amino acid residue segments) of each
molecule. Initial electron density maps were improved by density
modification using program DM in the CCP4 program suite (CCP4,
1994; locally modified to handle the large number of noncrystallo-
graphic symmetry [NCS] transformations). Two-fold NCS averaging
was performed for 37 subdivisions in β#, β, ω, and σ subunits, and
4-fold NCS averaging was performed for three subdivisions in αI
and αII subunits. Phases used for computing the density map
shown in Figure 3 (which showed minimal bias from the input
model coordinates) were derived from phase extension from 8 Å to
3 Å in 1000 cycles, with 0.25 weight applied to the input model-
derived phases (Stl coordinates not included in any model prior to
and at this stage) when combining with NCS-averaged and solvent-
flattened phases. Electron density maps generated by other ap-
proaches, including phase extension from 4 Å to 3 Å in 100–1000
cycles, were less clear. Rounds of refinement in CNS 1.1 used tor-
sion angle annealing, followed by 20 cycles of positional refine-
ment. The density-modified, NCS-averaged electron density maps
produced from the refined coordinates were used to model Stl and
to carry out manual model building of RNAP using the program O
(Jones et al., 1991). The most energetically stable conformers of
Stl were constructed and analyzed by conducting a systematic
search of Stl conformational space using molecular dynamics sim-
ulations in MOLOC (Gerber and Muller, 1995). Of ten lowest energy
conformers analyzed for best fit to the electron density map, one
could be fit with only minor bond rotation adjustments to the den-
sity in both RNAP molecules. Subsequent refinement and model
building cycles were performed, leading to the current crystallo-
graphic model, with a detwinned crystallographic residual of R =
0.261 and Rfree = 0.281 computed using all data with |Fo| > 0 be-
tween 30 Å and 3.0 Å resolution (Table 2). Successive rounds of
detwinning, as prescribed in Yeates (1997) and implemented in
CNS, resulted in considerable density-map improvement and per-
mitted unambiguous fitting of Stl into maps calculated from density
modification using DM, model refinement using CNS, and solvent
flipping using CNS following model refinement. Analogous pro-
cedures were used to refine the RNAP data set.
Supplemental Data
Supplemental Data include six figures and two tables and can be
found with this article online at http://www.cell.com/cgi/content/
full/122/4/541/DC1/.
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